SIGLEC1 and infection: SARS-CoV-2 S is extensively glycosylated with some of the complex glycans having terminal sialic acid residues [45,46], and a recent report demonstrated that DC-mediated SARS-CoV-2 trans infection of ACE2+ epithelial cells was facilitated by CD169 [14].